+65 3158 9940
1300 798 820
+64 9801 0299
Early in her career, Professor Anna Nowak treated a young woman who had just been diagnosed with the most serious type of brain cancer, a glioblastoma multiforme, or GBM. This terrible cancer has a grim prognosis. Most people diagnosed survive an average of just 15 months and the statistics have hardly improved in the past
Professor Antonio Di Ieva predicts and hopes that brain cancer will be a manageable chronic disease “much like diabetes” by 2030, and patients will have a vastly improved quality of life. Speaking to Specialised Therapeutics to mark Brain Tumour Awareness Month, the accomplished neurosurgeon, who has performed more than 2000 brain surgeries in the past
By Carlo Montagner, CEO Specialised Therapeutics Australia Dear PBS Improvements Section, My name is Carlo Montagner and I am the Chief Executive Officer and co-founder of Australia’s largest independent pharmaceutical company, Specialised Therapeutics Australia (STA). We are a wholly family-owned Australian company, supplying specialist therapies and technologies to patients throughout Australia, as well as in
See below, ST Asia’s Company Update / Annual Report for 2018/19. To view this publication, click on the cover image below.
Thousands of Australian women are affected by breast cancer every year. ST is committed to providing new therapies that can make a difference, but we also want to share the stories and experiences of those women who are diagnosed, as well as insights from some of Australia’s most respected oncologists. We’ve produced a breast cancer
Specialised Therapeutics CEO Carlo Montagner has appeared on a national business program, discussing the potential impact of the COVID-19 crisis on the global pharma supply chain, and the race for an effective COVID-19 vaccine and therapy. He told business journalist Ahron Young that ST’s Spanish partner PharmaMar is now fast-tracking trials of its myeloma compound
Respected Australian breast cancer surgeon Jane O’Brien discusses the Oncotype DX breast cancer assay. Click on the video banner above for more.
Like all companies globally, ST is closely monitoring the COVID-19 pandemic. In any kind of health crisis, all pharmaceutical companies must contribute their expertise to find answers. A key ST partner is Spanish company PharmaMar, which has announced its novel marine-derived multiple myeloma compound is showing encouraging laboratory results as a promising COVID-19 target. ST
The MZFF is extremely proud to be a foundation sponsor of the TLC Ambulance Project – an initiative developed by TLC for Kids in collaboration with Ambulance Victoria. This project will enable terminally ill children to be transported to a final destination of their choice – under the care of a full volunteer ambulance crew.
Specialised Therapeutics ensures its specialty medicines are transported seamlessly and reliably. Sophisticated planning makes this happen. Our Quality Assurance Manager and GxP Associate David Wilson explains below. OUR CAPABILITY: Specialised Therapeutics’ Quality Assurance Manager David Wilson explains how we transport specialist medicines to patients around the world What are the main considerations ST